#PekingUniversity Archives

Imatinib compared with second-generation tyrosine kinase inhibitors in persons with chronic myeloid leukemia presenting in accelerated phase

By Mourabit Halima 2024.03.07

In July 2023, a study led by Professor Qian Jiang from Peking University Institute of Hematology was published in the international academic journal ——American Journal of Hematology (IF=12.8). The title…

External Validation of Predictive Scoring Systems for Molecular Responses in Chronic Myeloid Leukemia Receiving Imatinib Therapy

By Mourabit Halima 2024.03.07

In September 2023, a study led by Professor Qian Jiang from Peking University Institute of Hematology was published in the international academic journal ——Leukemia(IF=11.4). The title of the study is…

ASCO-GU Interview | Dr. Tao Xu: Current status of precision treatment of prostate cancer and application of genetic testing

By Mourabit Halima 2024.03.05

Editor's Note: On January 25, 2024, the American Society of Clinical Oncology Genitourinary Cancers Symposium (ASCO-GU) marked its 20th anniversary in San Francisco, USA. On the occasion of the 20th…

Seven Achievements from Peking University Hepatology Institute Shine at EASL 2023

By Mourabit Halima 2023.12.25

From June 21st to 24th, the annual international liver disease conference, the 58th Annual Meeting of the European Association for the Study of the Liver (EASL 2023) and EASL Congress…